Tag: Merck

The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

FDA to Review Six sBLAs for KEYTRUDA

Merck
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review six supplemental Biologics License Applications (sBLA...

Merck and Utah University Found Potential Drug Target for Diabetes

Merck Research Laboratories and the University of Utah Health have shown that deactivation of the dihydroceramide desaturase 1 (DES1) enzyme could offer a potential drug target for metabolic diabetes....

Merck Terminated Incentive Agreement with Austin Tech Hub

Merck
Pharmaceutical giant Merck has notified City Manager Spencer Cronk that it is terminating its incentive agreement with the city effective June 23. As a result, Merck will not have to comply with the t...

ACIP Voted to Provisionally Update Recommendations for Hepatitis A Vaccination

merck
Merck, known as MSD outside the United States and Canada, announced that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) voted to upda...

Intensity Therapeutics and Merck Agreed to Conduct Clinical Research

Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary therapeutic agen...

KEYTRUDA® Approved as Monotherapy for Patients with Metastatic Small Cell Lung Cancer

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment ...

IBM, KPMG, MSD, and Walmart Take Part in FDA Pilot Program

fda
IBM, KPMG, Merck, and Walmart announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U.S. Drug Supply Cha...

Two New Indications for Merck’s KEYTRUDA Approved by FDA

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy in patients whose ...

MSD Acquires Tilos Therapeutics

Merck
Merck, known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical company deve...

Merck to Acquire Peloton Therapeutics

Merck, known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. today announced that the companies have entered into a definitive agreement under which Merck, through a subsid...

FDA Approved Bavencio for Treatment of Patients with Advanced Renal Cell Carcinoma

cancer-drugs
Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of patients with advanced ren...

WHO Changes Strategy in DRC Due to Unstable Merck Ebola Vaccine Supply

who
WHO’s Strategic Advisory Group of Experts (SAGE) today issued new recommendations to address vaccination challenges in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC). The ...

Merck to Buy Intermolecular

Merck, a leading science and technology company, has signed a definitive agreement to acquire Intermolecular Inc. through a subsidiary for $1.20 per share in an all cash transaction, representing an e...

Merck’s Keytruda Wins FDA’s Approval

The U.S. Food and Drug Administration has approved Merck & Co Inc’s cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with the most common type of kidney...

Merck Announced the Results of Clinical Research Trial of Pneumonia Drug

merck
Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from ASPECT-NP, a randomized, double-blind, multi-center Phase 3 clinical trial evaluating t...

Merck to Acquire Versum Materials

Merck, a leading science and technology company, has signed a definitive agreement to acquire Versum Materials, Inc. for $53 per share in cash. The business combination has been unanimously approved b...